Pieris Pharmaceuticals Price History

PIRSDelisted Stock  USD 13.60  1.41  9.39%   
If you're considering investing in Pieris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pieris Pharmaceuticals stands at 13.60, as last reported on the 28th of December, with the highest price reaching 15.35 and the lowest price hitting 13.26 during the day. Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Pieris Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pieris Pharmaceuticals' Coefficient Of Variation of (911.59), risk adjusted performance of (0.08), and Variance of 7.53 to confirm the risk estimate we provide.
  
Pieris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.113

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPIRS

Estimated Market Risk

 2.82
  actual daily
25
75% of assets are more volatile

Expected Return

 -0.32
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Pieris Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pieris Pharmaceuticals by adding Pieris Pharmaceuticals to a well-diversified portfolio.

Pieris Pharmaceuticals Stock Price History Chart

There are several ways to analyze Pieris Stock price data. The simplest method is using a basic Pieris candlestick price chart, which shows Pieris Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Pieris Stock Price History Data

The price series of Pieris Pharmaceuticals for the period between Sun, Sep 29, 2024 and Sat, Dec 28, 2024 has a statistical range of 3.7 with a coefficient of variation of 3.37. The price distribution for the period has arithmetic mean of 16.5. The median price for the last 90 days is 16.56. The company completed stock split (1:80) on 23rd of April 2024.
OpenHighLowCloseVolume
12/28/2024
 15.01  15.35  13.26  13.60 
12/13/2024 15.01  15.35  13.26  13.60  51,728 
12/12/2024 16.34  16.58  16.11  16.13  7,539 
12/11/2024 16.85  16.93  16.24  16.60  11,535 
12/10/2024 16.41  17.36  16.30  17.00  110,783 
12/09/2024 16.24  16.60  16.24  16.57  6,638 
12/06/2024 16.61  16.61  16.31  16.33  2,014 
12/05/2024 16.58  16.58  16.25  16.36  4,662 
12/04/2024 16.23  16.86  16.20  16.70  27,311 
12/03/2024 16.73  16.76  16.10  16.10  4,802 
12/02/2024 16.40  17.00  16.31  16.43  34,503 
11/29/2024 16.25  16.25  16.25  16.25  2,367 
11/27/2024 17.09  17.09  16.52  16.83  3,431 
11/26/2024 16.99  17.07  16.84  17.07  6,186 
11/25/2024 15.85  17.00  15.85  16.84  29,727 
11/22/2024 15.89  16.97  15.89  16.77  16,045 
11/21/2024 15.39  16.01  15.39  15.93  11,220 
11/20/2024 15.59  16.25  15.59  16.01  8,047 
11/19/2024 15.18  16.25  15.15  15.59  46,462 
11/18/2024 15.53  16.09  15.37  15.44  31,742 
11/15/2024 15.85  16.14  15.79  15.87  6,405 
11/14/2024 16.25  16.97  15.85  15.95  96,583 
11/13/2024 16.47  16.85  16.01  16.10  97,178 
11/12/2024 15.84  16.54  15.72  16.12  60,217 
11/11/2024 16.84  16.88  15.69  15.97  40,814 
11/08/2024 16.48  16.83  16.10  16.83  6,141 
11/07/2024 16.55  16.69  16.36  16.48  6,544 
11/06/2024 17.06  17.70  16.55  16.70  273,309 
11/05/2024 16.95  17.26  16.88  17.00  14,248 
11/04/2024 17.21  17.35  16.97  16.98  18,582 
11/01/2024 17.25  17.47  17.10  17.30  4,608 
10/31/2024 17.00  17.33  16.72  17.25  6,691 
10/30/2024 16.90  16.90  16.51  16.87  5,884 
10/29/2024 17.00  17.20  17.00  17.00  5,538 
10/28/2024 16.75  17.00  16.70  17.00  12,326 
10/25/2024 16.51  16.99  16.51  16.94  1,157 
10/24/2024 16.55  17.00  16.55  17.00  10,162 
10/23/2024 16.50  16.95  16.38  16.95  12,254 
10/22/2024 16.63  16.83  16.35  16.42  23,533 
10/21/2024 16.91  16.91  16.66  16.80  2,314 
10/18/2024 16.85  16.92  16.85  16.92  2,842 
10/17/2024 16.71  16.96  16.52  16.93  3,046 
10/16/2024 16.36  16.50  16.23  16.49  3,443 
10/15/2024 16.11  16.40  16.09  16.25  9,248 
10/14/2024 16.25  16.30  16.25  16.27  1,500 
10/11/2024 16.12  16.55  16.12  16.55  3,617 
10/10/2024 16.43  16.50  16.28  16.35  3,519 
10/09/2024 16.07  16.17  16.07  16.17  4,190 
10/08/2024 16.18  16.18  16.03  16.04  1,861 
10/07/2024 16.18  16.20  16.17  16.18  1,471 
10/04/2024 16.30  16.30  16.25  16.26  2,102 
10/03/2024 16.55  16.55  16.29  16.29  8,491 
10/02/2024 16.89  16.89  16.23  16.55  2,781 
10/01/2024 16.50  16.83  16.17  16.61  21,128 
09/30/2024 16.45  16.69  16.25  16.58  4,251 
09/27/2024 16.59  16.59  16.16  16.16  26,486 
09/26/2024 16.60  17.00  16.16  16.16  8,323 
09/25/2024 17.06  17.20  16.46  16.49  6,801 
09/24/2024 16.83  17.23  16.83  17.07  1,572 
09/23/2024 17.00  17.20  16.58  17.20  2,220 
09/20/2024 17.35  17.50  16.51  17.24  9,523 

About Pieris Pharmaceuticals Stock history

Pieris Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pieris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pieris Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pieris Pharmaceuticals stock prices may prove useful in developing a viable investing in Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts. Pieris Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people.

Pieris Pharmaceuticals Stock Technical Analysis

Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Pieris Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pieris Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Pieris Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Pieris Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Pieris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pieris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Pieris Stock

If you are still planning to invest in Pieris Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pieris Pharmaceuticals' history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation